Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ostrowski

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|October 6, 2005
Pulmonary function between 40 and 80 years of ageS Ostrowski, A Grzywa-Celińska, J Mieczkowska, et al.
Kardiologia Polska|January 1, 1985
[Clinical studies of the effectiveness of captopril in the treatment of chronic circulatory insufficiency]J Hanzlik, W Sodolski, A Wojnicz, et al.
Advances in Experimental Medicine and Biology|December 22, 1999
Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): electrocardiographic substudy--three months follow-upR Paulisiński, M Chibowska, A Biłan, et al.
Biotechnology and Applied Biochemistry|February 1, 1991
Stabilization of human prostatic acid phosphatase by coupling with chondroitin sulfateE Luchter-Wasylewska, J Dulińska, W S Ostrowski, et al.
Genes & Development|May 9, 1998
EGF domain swap converts a drosophila EGF receptor activator into an inhibitorB Schnepp, T Donaldson, G Grumbling, et al.
Acta Biochimica Polonica|January 1, 1988
Immunoreactivity of proteolytic degradation products of human prostatic acid phosphataseR Kuciel, A Mazurkiewicz, I Steuden, et al.
Biotechnology and Applied Biochemistry|June 1, 1988
Characterization of anti-prostatic acid phosphatase monoclonal antibody and its medical significanceR Kuciel, A Mazurkiewicz, W S Ostrowski, et al.
Advances in Experimental Medicine and Biology|December 22, 1999
Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): pulmonary substudy--effects of three month treatmentS Ostrowski, M Chibowska, A Biłan, et al.
Archives of Environmental Contamination and Toxicology|July 1, 1991
Lead exposure from conventional and cottage lead smelting in JamaicaT D Matte, J P Figueroa, S Ostrowski, et al.
Kardiologia Polska|January 1, 1989
[Prevalence of coronary disease risk factors in the male population 40-59 years of age from the housing complex "Czechów" in Lublin]J Hanzlik, J Tomaszewski, W Sodolski, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|October 6, 2005
Pulmonary function between 40 and 80 years of ageS Ostrowski, A Grzywa-Celińska, J Mieczkowska, et al.
Kardiologia Polska|January 1, 1985
[Clinical studies of the effectiveness of captopril in the treatment of chronic circulatory insufficiency]J Hanzlik, W Sodolski, A Wojnicz, et al.
Advances in Experimental Medicine and Biology|December 22, 1999
Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): electrocardiographic substudy--three months follow-upR Paulisiński, M Chibowska, A Biłan, et al.
Biotechnology and Applied Biochemistry|February 1, 1991
Stabilization of human prostatic acid phosphatase by coupling with chondroitin sulfateE Luchter-Wasylewska, J Dulińska, W S Ostrowski, et al.
Genes & Development|May 9, 1998
EGF domain swap converts a drosophila EGF receptor activator into an inhibitorB Schnepp, T Donaldson, G Grumbling, et al.
Acta Biochimica Polonica|January 1, 1988
Immunoreactivity of proteolytic degradation products of human prostatic acid phosphataseR Kuciel, A Mazurkiewicz, I Steuden, et al.
Biotechnology and Applied Biochemistry|June 1, 1988
Characterization of anti-prostatic acid phosphatase monoclonal antibody and its medical significanceR Kuciel, A Mazurkiewicz, W S Ostrowski, et al.
Advances in Experimental Medicine and Biology|December 22, 1999
Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): pulmonary substudy--effects of three month treatmentS Ostrowski, M Chibowska, A Biłan, et al.
Archives of Environmental Contamination and Toxicology|July 1, 1991
Lead exposure from conventional and cottage lead smelting in JamaicaT D Matte, J P Figueroa, S Ostrowski, et al.
Kardiologia Polska|January 1, 1989
[Prevalence of coronary disease risk factors in the male population 40-59 years of age from the housing complex "Czechów" in Lublin]J Hanzlik, J Tomaszewski, W Sodolski, et al.
Pageof 9